Mimedx Group Inc. agreed to buy Sanara Medtech Inc. in a cash and stock deal for a total enterprise value of approximately $350 million as it looks to expand its surgical footprint. The move is part of Mimedx strategy to transform the company after its wound care business was hit on the back of CMS changes to reimbursement for skin substitutes.